ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million

August 19, 1983

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

March 31, 2000

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979